These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 4984475)
1. Methyldopa-chlorothiazide--a long-term evaluation. Klapper MS; Richard LS; Smith GH South Med J; 1970 Jan; 63(1):77-81. PubMed ID: 4984475 [No Abstract] [Full Text] [Related]
2. Antihypertensive efficacy of alpha-methyldopa, chlorothiazide and Supres-150 (alpha-methyldopa-chlorothiazide). Fernandez PG; Zachariah PK; Bryant DG; Missan SS Can Med Assoc J; 1980 Aug; 123(4):284-7. PubMed ID: 7020900 [TBL] [Abstract][Full Text] [Related]
3. Positive direct antiglobulin reactions and methyldopa. Klapper MS; Noto TA Ala J Med Sci; 1968 Jul; 5(3):421-7. PubMed ID: 5315985 [No Abstract] [Full Text] [Related]
4. [Autoimmune hemolytic anemia induced by alpha methyldopa]. del Valle y Fuentes F; Alvarez Amaya C; González Llaven J; López Gómez SA; Galván V; Aguirre Olvera O Arch Inst Cardiol Mex; 1979; 49(3):491-6. PubMed ID: 475504 [TBL] [Abstract][Full Text] [Related]
8. Drug induced hemolytic anemia. Lobell M; Woodburn R Minn Med; 1975 Mar; 58(3):239-43. PubMed ID: 1113723 [No Abstract] [Full Text] [Related]
9. Haematological effects of methyldopa. Cantor S; Barnett AJ Lancet; 1967 Mar; 1(7490):625. PubMed ID: 4163991 [No Abstract] [Full Text] [Related]
10. Prevention of hyperuricemia by allopurinol in hypertensive patients treated with chlorothiazide. Nicotero JA; Scheib ET; Martinez R; Rodnan GP; Shapiro AP N Engl J Med; 1970 Jan; 282(3):133-5. PubMed ID: 4902227 [No Abstract] [Full Text] [Related]
11. Adverse effects of methyldopa. Med Lett Drugs Ther; 1968 Mar; 10(6):22-3. PubMed ID: 5646501 [No Abstract] [Full Text] [Related]
12. Methyldopa and haemolytic anaemia. Louis WJ; Doyle AE; Jerums G; Kincaid-Smith P Med J Aust; 1967 Jul; 2(3):104-6. PubMed ID: 6031263 [No Abstract] [Full Text] [Related]
13. Hypertension: the general practitioner's approach to the problem, with special reference to the use of methyldopa (Aldomet). Du Toit JK S Afr Med J; 1970 Aug; 44(32):924-6. PubMed ID: 4394147 [No Abstract] [Full Text] [Related]
14. Studies on patients receiving alpha-methyldopa: observations on red cell life span. Spector I; Joffe BI; Zoutendyk A; Fraser B; Spitz IM; Dubb A; Kew MD; Jones GC; Hart D S Afr Med J; 1968 Apr; 42(14):339-42. PubMed ID: 4171955 [No Abstract] [Full Text] [Related]
15. Acquired hemolytic anemia with unusual serological characteristics probably caused by alpha-methyldopa. Robinson S Can J Med Technol; 1970 Oct; 32(5):188-95. PubMed ID: 5480713 [No Abstract] [Full Text] [Related]
16. Coombs positive haemolytic anaemia due to methyldopa. Roy A; Ghosh ML Br J Clin Pract; 1981 Jan; 35(1):54, 58. PubMed ID: 7259945 [No Abstract] [Full Text] [Related]
17. [Studies on the drug-induced hemolytic anemia in Japan (author's transl)]. Tsunematsu T; Matsurashi C Rinsho Ketsueki; 1979 Jul; 20(7):724-36. PubMed ID: 501996 [No Abstract] [Full Text] [Related]
18. [Hemolytic anemia after treatment with methyldopa]. Ekman S; Alinder I Lakartidningen; 1970 Dec; 67(50):5866-7. PubMed ID: 5491057 [No Abstract] [Full Text] [Related]